Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Telomere-associated genes and telomeric lncRNAs are biomarker candidates in lung squamous cell carcinoma (LUSC)

Full text
Storti, Camila Baldin [1, 2] ; de Oliveira, Rogerio Antonio [3] ; de Carvalho, Marcio [4] ; Hasimoto, Erica Nishida [5] ; Cataneo, Daniele Cristina [5] ; Maria Cataneo, Antonio Jose [5] ; De Faveri, Julio [6] ; Vasconcelos, Elton Jose R. [7] ; dos Reis, Patricia Pintor [5, 8] ; Nogueira Cano, Maria Isabel [1]
Total Authors: 10
[1] Sao Paulo State Univ UNESP, Biosci Inst, Genet Dept, Botucatu, SP - Brazil
[2] Univ Sao Paulo, Fac Med, Genet Dept, Ribeirao Preto, SP - Brazil
[3] Sao Paulo State Univ UNESP, Biostat Dept, Biosci Inst, Botucatu, SP - Brazil
[4] Sao Paulo State Univ UNESP, Fac Vet Med & Anim Sci, Fac Med, Botucatu, SP - Brazil
[5] Sao Paulo State Univ UNESP, Fac Med, Dept Surg & Orthoped, Botucatu, SP - Brazil
[6] Sao Paulo State Univ UNESP, Fac Med, Dept Pathol, Botucatu, SP - Brazil
[7] Univ Leeds, Leeds Omics, Leeds, W Yorkshire - England
[8] Sao Paulo State Univ UNESP, Fac Med, Expt Res Unity UNIPEX, Botucatu, SP - Brazil
Total Affiliations: 8
Document type: Journal article
Source: Experimental and Molecular Pathology; v. 112, FEB 2020.
Web of Science Citations: 0

In the past decade, research efforts were made to identify molecular biomarkers useful as therapeutic targets in Non-Small Cell Lung Cancer (NSCLC), the most frequent type of lung carcinoma. NSCLC presents different histological subtypes being the most prevalent LUSC (Lung Squamous Cell Cancer) and LUAD (Lung Adenocarcinoma), and only a subset of LUAD patients' present tumors expressing known targetable genetic alterations. Telomeres and its components, including telomerase, the enzyme that replenishes telomeres, have been considered potential cancer biomarkers due to their crucial role in cell proliferation and genome stability. Our study aims to quantify expression changes affecting telomere-associated genes and ncRNAs associated with telomere regulation and maintenance in NSCLC. We first assessed the transcriptome (RNA-Seq) data of NSCLC patients from The Cancer Genome Atlas (TCGA) and then we tested the expression of telomere-associated genes and telomeric ncRNAs (TERC, telomerase RNA component, and TERRA, telomere repeat-containing RNA) in Brazilian NCSLC patient samples by quantitative RT-PCR, using matched normal adjacent tissue samples as the control. We also estimated the mean size of terminal restriction fragments (TRF) of some Brazilian NSCLC patients using telomeric Southern blot. The TCGA analysis identified alterations in the expression profile of TERT and telomere damage repair genes, mainly in the LUSC subtype. The study of Brazilian NSCLC samples by RT-qPCR showed that LUSC and LUAD express high amounts of TERT and that although the mean TRF size of tumor samples was shorter compared to normal cells, telomeres in NSCLC are probably maintained by telomerase. Also, the expression analysis of Brazilian NSCLC samples identified statistically significant alterations in the expression of genes involved with telomere damage repair, as well as in TERC and TERRA, mainly in the LUSC subtype. We, therefore, concluded that telomere maintenance genes are significantly deregulated in NSCLC, representing potential biomarkers in the LUSC subtype. (AU)

FAPESP's process: 16/06936-6 - Genes and telomeric proteins as biomarkers in non-small cell lung cancer (NSCLC)
Grantee:Camila Baldin Storti
Support Opportunities: Scholarships in Brazil - Master
FAPESP's process: 12/50161-8 - Study of the structure and function of the Hsp90 chaperone with emphasis on its role in cellular homeostasis
Grantee:Carlos Henrique Inacio Ramos
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 11/13213-7 - Prognostic biomarkers in non-small cell lung cancer: identification of potential therapeutic targets
Grantee:Patricia Pintor dos Reis
Support Opportunities: Regular Research Grants